HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection
Alberto Beretta, Antonio G. Siccardi(San Raffaele University of Rome), Maria Elena Dinelli(Vita-Salute San Raffaele University), Lucinda Furci(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Lucia Lopalco(Vita-Salute San Raffaele University), Mario Clerici(University of Milan), Sergio Sabbatani(Ospedale Maggiore Carlo Alberto Pizzardi), Giuseppe Tambussi(San Raffaele University of Rome), C. De Santis(University of Milan), Emily Carrow(Vita-Salute San Raffaele University), Samuele E. Burastero(Vita-Salute San Raffaele University), Antonio Cosma(Luxembourg Institute of Health)
Cited by 32
Related Papers
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391